Dr. Alan Randall Anderson, MD

Dr. Anderson practices at Prisma Health Greenville Memorial Hospital in Greenville, South Carolina, part of Prisma Health.

Dr. Anderson's NPI, 1124175146, was assigned on January 4, 2007. Dr. Anderson graduated from Medical University of South Carolina (MUSC) in 2001. Dr. Anderson holds South Carolina license 24783.

Dr. Anderson's primary practice is Prisma Health Greenville Memorial Hospital, at 701 Grove Road, Greenville, SC 29605 in Greenville County. The practice phone is (864) 455-7000.

Dr. Anderson's primary practice is Prisma Health Greenville Memorial Hospital in Greenville, South Carolina, part of Prisma Health. The medical group on file is Prisma Health Medical Group. Dmand AI also links Dr. Anderson to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anderson practices, 3 sites in all. Vendor and product names are available with a free account.

Pediatric hematology-oncology is Dr. Anderson's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Anderson is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Anderson's licenses on file in 2 states: South Carolina and Georgia.

Dmand AI lists deep vein thrombosis (DVT) among the conditions Dr. Anderson treats.

CMS data shows 73 Medicare services from Dr. Anderson across 1 procedure code in 2024, all of them office visits, for 26 Medicare patients. Medicare paid $7,123 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 26 Medicare patients who saw Dr. Anderson in 2024. 54% of them have anxiety, and 46% have mood disorders. Their average risk score is 4.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Anderson's median patient age at 16, with 57% women.

In 2024, Dr. Anderson wrote 985 Medicare Part D claims for 51 patients. 82% of them were for generic drugs. CMS names the drug for 780 of them, across 23 drugs with 11 or more claims each, at $608,233 in total drug cost. In 2023, CMS named 1,121 claims across 29 drugs.

Dr. Anderson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Anderson, published from 2008 to 2024. 2022 was the busiest year, with 2. The most frequent topics are Anemia, Sickle Cell, Benzaldehydes and Erythrocyte Transfusion. Dr. Anderson has published most often in Eur J Haematol. Dr. Anderson's most frequent co-authors are Cassandra D. Josephson, MD, Charles S. Abrams, MD and Aaron M. Anderson, MD.

Dmand AI links Dr. Anderson to 2 clinical trials. Conditions studied include Anemia, Sickle Cell, Priapism and Anemia, Hemolytic, Congenital.

CMS Open Payments shows 412 general payments to Dr. Anderson from 30 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 39% of the total. Global Blood Therapeutics, Inc. paid the most, $238,675. It also lists 18 research payments totaling $19,152 from 2022 to 2025.

Dr. Anderson graduated from Medical University of South Carolina (MUSC) in 2001.

Dr. Anderson is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.